CT attenuation of liver metastases before targeted therapy is a prognostic factor of overall survival in colorectal cancer patients. Results from the randomised, open-label FIRE-3/AIO KRK0306 trial
Journal article published in 2018 by
Matthias F. Froelich 
,
Volker Heinemann,
Wieland H. Sommer,
Julian W. Holch,
Franziska Schoeppe,
Nina Hesse,
Alena B. Baumann,
Wolfgang G. Kunz,
Maximilian F. Reiser,
Jens Ricke,
Melvin D’Anastasi,
Sebastian Stintzing,
Dominik P. Modest,
Philipp M. Kazmierczak,
Felix O. Hofmann
,
Volker Heinemann,
Wieland H. Sommer,
Julian W. Holch,
Franziska Schoeppe,
Nina Hesse,
Alena B. Baumann,
Wolfgang G. Kunz,
Maximilian F. Reiser,
Jens Ricke,
Melvin D’Anastasi,
Sebastian Stintzing,
Dominik P. Modest,
Philipp M. Kazmierczak,
Felix O. Hofmann
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 